Protegrin structure and activity against Neisseria gonorrhoeae

Infection and Immunity

Volumn 65, Issue 2, 1997, Pages 636-639

  Qu, Xiao Dan ^a   Harwig, Sylvia S L ^a   Shafer, William M ^b,c   Lehrer, Robert I ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ATLANTA VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ANTIINFECTIVE AGENT; ARGININE; CYSTINE; GLYCINE; OLIGOSACCHARIDE; PROTEGRIN; UNCLASSIFIED DRUG;

ARTICLE; BACTERIUM TRANSFORMATION; CONTROLLED STUDY; DISULFIDE BOND; MINIMUM INHIBITORY CONCENTRATION; NEISSERIA GONORRHOEAE; NONHUMAN; PRIORITY JOURNAL; PROTEIN VARIANT; SERUM; STRUCTURE ACTIVITY RELATION;

EID: 0031034573     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.65.2.636-639.1997     Document Type: Article

References (17)

1. Aumelas, A., M. Mangoni, C. Roumestand, L. Chiche, E. Despaux, G. Grassy, B. Calas, and A. Chavanieu. 1996. Synthesis and solution structure of the antimicrobial peptide protegrin-1. Eur. J. Biochem. 237:575-583.
2. Bensch, K. W., M. Raida, H. J. Magert, P. Schulz-Knappe, and W. G. Forssmann. 1995. hBD-1: a novel beta-defensin from human plasma. FEBS Lett. 368:331-335.
3. Cannon, J. G., T. J. Lee, L. F. Guymon, and P. F. Sparling. 1981. Genetics of serum resistance in Neisseria gonorrhoeae: the sac-1 genetic locus. Infect. Immun. 32:547-552.
4. Fahrner, R. L., T. Dieckmann, S. S. L. Harwig, R. I. Lehrer, and J. Feigon. 1996. Solution structure of protegrin 1, a broad spectrum antimicrobial peptide from porcine leukocytes. Chem. Biol. 3:543-550.
5. Ganz, T., and R. I. Lehrer. 1994. Defensins. Curr. Opin. Immunol. 6:584-589.
6. Harwig, S. S. L., K. M. Swiderek, T. D. Lee, and R. I. Lehrer. 1995. Determination of disulphide bridges in PG-2, an antimicrobial peptide from porcine leukocytes. J. Peptide Sci. 3:207-215.
7. Harwig, S. S. L., A. Waring, H.-J. Yang, Y. Cho, L. Tan, and R. I. Lehrer. 1996. Intramolecular disulfide bonds enhance the antimicrobial and lytic activities of protegrins at physiological sodium chloride concentrations. Eur. J. Biochem. 240:352-357.
8. Jones, D. E., and C. L. Bevins. 1992. Paneth cells of the human small intestine express an antimicrobial peptide gene. J. Biol. Chem. 267:23216-23225.
9. Jones, D. E., and C. L. Bevins. 1993. Defensin-6 mRNA in human Paneth cells: implications for antimicrobial peptides in host defense of the human bowel. FEBS Lett. 315:187-192.
10. Kokryakov, V. N., S. S. L. Harwig, E. A. Panyutich, A. A. Shevchenko, G. M. Aleshina, O. V. Shamova, H. A. Korneva, and R. I. Lehrer. 1993. Protegrins, leukocyte antimicrobial peptides that combine features of corticostatic defensins and tachyplesins. FEBS Lett. 327:231-236.
11. Lucas, C. E., K. E. Hagman, J. C. Levin, D. C. Stein, and W. M. Shafer. 1995. Importance of lipooligosaccharide structure in determining gonococcal resistance to hydrophobic antimicrobial agents resulting from the mtr efflux system. Mol. Microbiol. 16:1001-1009.
12. Mallow, E. B., A. Harris, N. Salzman, J. P. Russell, R. J. DeBerardinis, E. Ruchelli, and C. L. Bevins. 1996. Human enteric defensins. Gene structure and developmental expression. J. Biol. Chem. 271:4038-4045.
13. Qu, X.-D., S. S. L. Harwig, A. Oren, W. M. Shafer, and R. I. Lehrer. 1996. Susceptibility of Neisseria gonorrhoeae to protegrins. Infect. Immun. 64:1240-1245.
14. +) in Neisseria gonorrhoeae that affects sensitivity to normal human serum. Infect. Immun. 35:764-769.
15. Tam, J. P., C.-R. Wu, W. Liu, and J.-W. Zang. 1991. Disulfide bond formation in peptides by dimethyl sulfoxide. Scope and application. J. Am. Chem. Soc. 113:6657-6662.
16. Tamamura, H., T. Murakami, S. Horiuchi, K. Sugihara, A. Otaka, W. Takada, T. Ibuka, M. Waki, N. Yamamoto, and N. Fujii. 1995. Synthesis of protegrin-related peptides and their antibacterial and anti-human immunodeficiency virus activity. Chem. Pharm. Bull. 43:853-858.
17. Yasin, B., S. S. L. Harwig, R. I. Lehrer, and E. A. Wagar. 1996. Susceptibility of Chlamydia trachomatis to protegrins and defensins. Infect. Immun. 64: 709-713.